Veeva Systems Unveils Falcon AI Platform to Enhance Drug Development Processes

Veeva Systems (VEEV) introduced Falcon, an agentic platform designed for life sciences drug development. The company also secured CRM commitments from Merck KGaA and Teva Pharmaceuticals while expanding its Quality Cloud deployment with Kindeva.

By Faheem Tahir Mon, June 1, 2026 at 4:48 PM GMT+3 2 min read · Yahoo Finance · June 1, 2026, 13:48 UTC

Veeva Systems Unveils Falcon AI Platform to Enhance Drug Development Processes

Tickers: $MRK $TEVA $VEEV

Topics: AI automation CRM adoption drug development life sciences

Read the full article at Yahoo Finance

More World news

Thomson Reuters Executives to Present at TD Securities Technology Conference PR Newswire · November 12, 2026, 16:00 UTC
BHP to Restructure Australian Iron Ore Operations Amid Rising Costs Seeking Alpha · November 12, 2026, 15:59 UTC
Capri Investment Group and GRIT Chicago Unveil $10 Billion Bronzeville Lakefront Development Plan PR Newswire · November 12, 2026, 16:00 UTC
Whoop Launches 'Whoop Humans' Social Network to Enhance Health Data Sharing TechCrunch · November 12, 2026, 16:00 UTC
SchoolWise Partners Advises on Sale of Wyalusing Valley and Wysox Children's Centers PR Newswire · November 12, 2026, 15:57 UTC
Jensen Huang Resigns as Nvidia CEO Amid Personal Scandal and Leadership Crisis CNBC · November 12, 2026, 15:45 UTC
Keurig Dr Pepper Launches $2 Billion Equity Offering to Reduce Debt Ahead of Corporate Split Seeking Alpha · November 12, 2026, 15:51 UTC
Old National Bancorp Announces Quarterly Dividend of $0.4375 per Share Seeking Alpha · November 12, 2026, 15:53 UTC
Old National Bancorp Announces Quarterly Dividend of $0.4375 per Share Seeking Alpha · November 12, 2026, 15:53 UTC
Oman Investment Authority Signs Multi-Billion Dollar Investment Package with Chinese Partners PR Newswire · November 12, 2026, 15:52 UTC